美农生物
(301156)
| 流通市值：10.27亿 | | | 总市值：21.68亿 |
| 流通股本：6878.20万 | | | 总股本：1.45亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 377,541,958.9 | 359,853,060.69 | 309,903,573.02 | 316,815,075.78 |
| 结算备付金 | 0 | 0 | - | - |
| 拆出资金 | 0 | 0 | - | - |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 70,173,311.54 | 78,034,775.75 | 100,506,516.98 | 88,777,906.75 |
| 其中：应收票据 | 350,000 | 200,000 | 1,843,000 | 4,769,700.5 |
| 应收账款 | 69,823,311.54 | 77,834,775.75 | 98,663,516.98 | 84,008,206.25 |
| 应收款项融资 | 386,775 | 669,900 | 669,900 | - |
| 预付款项 | 8,911,324.32 | 8,467,858.25 | 7,802,200.61 | 8,297,187 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 379,780.21 | 247,061.41 | 506,489.88 | 446,462.81 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 0 | 0 | - | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 69,068,331.15 | 77,712,454.91 | 86,833,153.44 | 84,324,735.14 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 0 | 0 | - | - |
| 其他流动资产 | 5,868,027.2 | 5,486,641.85 | 5,465,345.75 | 5,646,531.62 |
| 流动资产其他项目 | 0 | 0 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 557,442,486.51 | 560,530,252.86 | 562,845,215.04 | 525,428,229.74 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | - |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 0 | 0 | - | - |
| 长期股权投资 | 22,281,193.94 | 22,950,299 | 22,416,688.27 | 22,010,357.54 |
| 其他权益工具投资 | 0 | 0 | - | - |
| 其他非流动金融资产 | 2,443,359.68 | 1,912,627.92 | 1,932,800 | 1,744,000 |
| 投资性房地产 | 0 | 0 | - | - |
| 固定资产 | 200,572,064.68 | 205,485,116.69 | 186,650,350.73 | 176,825,061.39 |
| 在建工程 | 12,431,306.33 | 11,677,844.87 | 26,613,596.19 | 36,865,877.22 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 1,302,103.97 | 1,521,187.88 | 1,740,271.79 | 1,959,355.7 |
| 无形资产 | 28,228,138.04 | 28,556,081.72 | 28,027,196.56 | 28,190,180.95 |
| 开发支出 | 0 | 0 | - | - |
| 商誉 | 0 | 0 | - | - |
| 长期待摊费用 | 1,564,320.52 | 1,481,938.41 | 1,460,841.97 | 1,730,348.15 |
| 递延所得税资产 | 2,156,233.78 | 3,367,986.26 | 3,459,266.17 | 3,207,540.21 |
| 其他非流动资产 | 1,668,825.18 | 1,340,497.1 | 5,564,023.27 | 4,043,374.54 |
| 非流动资产其他项目 | 0 | 0 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 272,647,546.12 | 278,293,579.85 | 277,865,034.95 | 276,576,095.7 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 830,090,032.63 | 838,823,832.71 | 840,710,249.99 | 802,004,325.44 |
| 流动负债: | | | | |
| 短期借款 | 1,000,886.11 | 0 | 0 | - |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 15,020,859.92 | 17,067,449.87 | 30,001,310.61 | 23,286,889.4 |
| 其中：应付票据 | 0 | 0 | 0 | - |
| 应付账款 | 15,020,859.92 | 17,067,449.87 | 30,001,310.61 | 23,286,889.4 |
| 预收款项 | 0 | 0 | - | - |
| 合同负债 | 667,218.91 | 715,274.69 | 2,510,538.79 | 1,569,561.81 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 6,087,484.47 | 16,165,165.01 | 15,158,050.12 | 9,882,022.1 |
| 应交税费 | 345,879.14 | 1,941,343.87 | 3,458,893.95 | 2,143,579.31 |
| 其他应付款合计 | 728,996.18 | 902,763.61 | 856,354.97 | 734,156.54 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | 0 | 0 | - | - |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 905,770.55 | 897,333.85 | 866,558.27 | 865,819.98 |
| 其他流动负债 | 216,651.01 | 225,189.06 | 1,800,683.49 | 2,235,717.79 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 24,973,746.29 | 37,914,519.96 | 54,652,390.2 | 40,717,746.93 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 0 | - | - |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 229,543.86 | 227,074.44 | 750,323.07 | 735,610.41 |
| 长期应付款 | 0 | 0 | - | - |
| 长期应付职工薪酬 | 0 | 0 | - | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 1,515,499.97 | 1,576,992.77 | 1,595,248.16 | 1,555,922.26 |
| 递延所得税负债 | 0 | 0 | 276,125.3 | 242,149.6 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,745,043.83 | 1,804,067.21 | 2,621,696.53 | 2,533,682.27 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 26,718,790.12 | 39,718,587.17 | 57,274,086.73 | 43,251,429.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 112,000,000 | 112,000,000 | 112,000,000 | 112,000,000 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 398,024,626.66 | 398,024,626.66 | 395,624,413.3 | 395,624,413.3 |
| 减:库存股 | 5,317,926.24 | 0 | - | - |
| 其他综合收益 | 0 | 0 | - | - |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 39,184,573.11 | 39,184,573.11 | 34,363,247.95 | 34,363,247.95 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | 259,479,968.98 | 249,896,045.77 | 241,448,502.01 | 216,765,234.99 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 803,371,242.51 | 799,105,245.54 | 783,436,163.26 | 758,752,896.24 |
| 少数股东权益 | 0 | 0 | - | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 803,371,242.51 | 799,105,245.54 | 783,436,163.26 | 758,752,896.24 |
| 负债和股东权益合计 | 830,090,032.63 | 838,823,832.71 | 840,710,249.99 | 802,004,325.44 |
| 公告日期 | 2024-04-25 | 2024-04-09 | 2023-10-27 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |